Volitionrx (VNRX) Receivables - Other (2018 - 2019)
Volitionrx (VNRX) reported Receivables - Other of $1.0 million for Q3 2019, little changed on a YoY basis from $1.0 million in Q3 2018, and little changed quarter-over-quarter from $1.0 million in Q4 2018.
Volitionrx (VNRX) Receivables - Other (2018 - 2019) Analysis & Trends
Volitionrx has reported Receivables - Other for 2 years, with the latest figure at $1.0 million in Q3 2019.
- For the quarter ending Q3 2019, Receivables - Other changed 0.0% year-over-year to $1.0 million; the trailing twelve-month figure through Sep 2019 stood at $1.0 million (changed 0.0% YoY), and the FY2018 full-year result was $1.0 million, changed N/A from the prior year.
- Receivables - Other for Q3 2019 stood at $1.0 million, roughly flat from $1.0 million in the prior quarter.
- The five-year high for Receivables - Other was $1.0 million in Q3 2018, with the low at $1.0 million in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Volitionrx | 53.00 Mn | 50.54 Mn | -1.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 1.05 Mn |
| Sep 30, 2019 | 1.05 Mn |
| Dec 31, 2018 | 1.05 Mn |
| Dec 31, 2018 | 1.05 Mn |
| Sep 30, 2018 | 1.05 Mn |
| Sep 30, 2018 | 1.05 Mn |